| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1724 | 2019 |
| Defective suppressor function in CD4+ CD25+ T-cells from patients with type 1 diabetes S Lindley, CM Dayan, A Bishop, BO Roep, M Peakman, TIM Tree Diabetes 54 (1), 92-99, 2005 | 1139 | 2005 |
| Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study L Monin, AG Laing, M Muñoz-Ruiz, DR McKenzie, IDM Del Barrio, ... The Lancet Oncology 22 (6), 765-778, 2021 | 591 | 2021 |
| Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health S Arif, TI Tree, TP Astill, JM Tremble, AJ Bishop, CM Dayan, BO Roep, ... The Journal of clinical investigation 113 (3), 451-463, 2004 | 583 | 2004 |
| CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope A Skowera, RJ Ellis, R Varela-Calviño, S Arif, GC Huang, C Van-Krinks, ... The Journal of clinical investigation 118 (10), 3390-3402, 2008 | 455 | 2008 |
| Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death S Arif, F Moore, K Marks, T Bouckenooghe, CM Dayan, R Planas, ... Diabetes 60 (8), 2112-2119, 2011 | 260 | 2011 |
| Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+ CD25+ regulatory T cell function G Garg, JR Tyler, JHM Yang, AJ Cutler, K Downes, M Pekalski, GL Bell, ... The Journal of Immunology 188 (9), 4644-4653, 2012 | 245 | 2012 |
| Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes JM Lawson, J Tremble, C Dayan, H Beyan, RDG Leslie, M Peakman, ... Clinical & Experimental Immunology 154 (3), 353-359, 2008 | 220 | 2008 |
| Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it? CM Hull, M Peakman, TIM Tree Diabetologia 60 (10), 1839-1850, 2017 | 193 | 2017 |
| Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes M Alhadj Ali, YF Liu, S Arif, D Tatovic, H Shariff, VB Gibson, N Yusuf, ... Science translational medicine 9 (402), eaaf7779, 2017 | 188 | 2017 |
| The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study SK Mahil, K Bechman, A Raharja, C Domingo-Vila, D Baudry, MA Brown, ... The Lancet Rheumatology 3 (9), e627-e637, 2021 | 165 | 2021 |
| Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis CH Lu, K Allen, F Oei, E Leoni, J Kuhle, T Tree, P Fratta, N Sharma, ... Neurology: Neuroimmunology & Neuroinflammation 3 (4), e244, 2016 | 159 | 2016 |
| Immune modulation in humans: implications for type 1 diabetes mellitus BO Roep, TIM Tree Nature Reviews Endocrinology 10 (4), 229-242, 2014 | 155 | 2014 |
| CD 161 expression characterizes a subpopulation of human regulatory T cells that produces IL‐17 in a STAT 3‐dependent manner B Afzali, PJ Mitchell, FC Edozie, GAM Povoleri, SE Dowson, L Demandt, ... European journal of immunology 43 (8), 2043-2054, 2013 | 153 | 2013 |
| Phenotypic complexity of the human regulatory T cell compartment revealed by mass cytometry GM Mason, K Lowe, R Melchiotti, R Ellis, E de Rinaldis, M Peakman, ... The Journal of Immunology 195 (5), 2030-2037, 2015 | 150 | 2015 |
| Regulatory T cell responses in participants with type 1 diabetes after a single dose of interleukin-2: a non-randomised, open label, adaptive dose-finding trial JA Todd, M Evangelou, AJ Cutler, ML Pekalski, NM Walker, HE Stevens, ... PLoS medicine 13 (10), e1002139, 2016 | 144 | 2016 |
| Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture JS Allen, K Pang, A Skowera, R Ellis, C Rackham, B Lozanoska-Ochser, ... Diabetes 58 (1), 138-145, 2009 | 138 | 2009 |
| Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression TIM Tree, J Lawson, H Edwards, A Skowera, S Arif, BO Roep, M Peakman Diabetes 59 (6), 1451-1460, 2010 | 118 | 2010 |
| Generation of human islet-specific regulatory T cells by TCR gene transfer CM Hull, LE Nickolay, M Estorninho, MW Richardson, JL Riley, ... Journal of autoimmunity 79, 63-73, 2017 | 116 | 2017 |
| C-peptide decline in type 1 diabetes has two phases: an initial exponential fall and a subsequent stable phase BM Shields, TJ McDonald, R Oram, A Hill, M Hudson, P Leete, ... Diabetes care 41 (7), 1486-1492, 2018 | 103 | 2018 |
